Support Alert

Class 4 Medicines Defect Information: Morningside Healthcare Limited, Hyoscine Butylbromide 20 mg Film-coated Tablets

Morningside Healthcare Limited has informed the Medicines and Healthcare Products Regulatory Agency (MHRA) of an error with the Patient Information Leaflet (PIL) packaged in a batch of Hyoscine Butylbromide 20 mg Film-coated Tablets. Some packs within the batch may contain a PIL for Midodrine Hydrochloride 2.5 mg & 5 mg Tablets.


Further information, advice and details of the affected batch can be found on the MHRA website.